Han Y - Search Results

1

Different roles of two novel susceptibility loci for nonsyndromic orofacial clefts in a Chinese Han population.

Pan Y, Zhang W, Du Y, Tong N, Han Y, Zhang H, Wang M, Ma J, Wan L, Wang L. Pan Y, et al. Among authors: han y. Am J Med Genet A. 2011 Sep;155A(9):2180-5. doi: 10.1002/ajmg.a.34170. Epub 2011 Aug 10. Am J Med Genet A. 2011. PMID: 21834038

2

Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and nonsyndromic orofacial clefts susceptibility in a southern Chinese population.

Han Y, Pan Y, Du Y, Tong N, Wang M, Zhang Z, Wan L, Wang L. Han Y, et al. DNA Cell Biol. 2011 Dec;30(12):1063-8. doi: 10.1089/dna.2010.1185. Epub 2011 May 25. DNA Cell Biol. 2011. PMID: 21612398

3

Association and cumulative effects of GWAS-identified genetic variants for nonsyndromic orofacial clefts in a Chinese population.

Pan Y, Han Y, Zhang H, Zhou L, Li D, Cai Q, Ma J, Zhang W, Wang L. Pan Y, et al. Among authors: han y. Environ Mol Mutagen. 2013 May;54(4):261-7. doi: 10.1002/em.21773. Epub 2013 Mar 27. Environ Mol Mutagen. 2013. PMID: 23536526

4

The axis inhibition protein 2 polymorphisms and non-syndromic orofacial clefts susceptibility in a Chinese Han population.

Han Y, Zhou L, Ma L, Li D, Xu M, Yuan H, Ma J, Zhang W, Jiang H, Wu Y, Wang L, Pan Y. Han Y, et al. J Oral Pathol Med. 2014 Aug;43(7):554-60. doi: 10.1111/jop.12162. Epub 2014 Feb 1. J Oral Pathol Med. 2014. PMID: 24484320

5

Associations between microRNA binding site SNPs in FGFs and FGFRs and the risk of non-syndromic orofacial cleft.

Li D, Zhang H, Ma L, Han Y, Xu M, Wang Z, Jiang H, Zhang W, Wang L, Pan Y. Li D, et al. Among authors: han y. Sci Rep. 2016 Aug 11;6:31054. doi: 10.1038/srep31054. Sci Rep. 2016. PMID: 27511275 Free PMC article.

6

PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment.

Zhu X, Ji M, Han Y, Guo Y, Zhu W, Gao F, Yang X, Zhang C. Zhu X, et al. Among authors: han y. Int J Oncol. 2017 Mar;50(3):835-846. doi: 10.3892/ijo.2017.3873. Epub 2017 Feb 10. Int J Oncol. 2017. PMID: 28197632

7

Engineering a high-affinity humanized anti-CD24 antibody to target hepatocellular carcinoma by a novel CDR grafting design.

Sun F, Wang T, Jiang J, Wang Y, Ma Z, Li Z, Han Y, Pan M, Cai J, Wang M, Zhang J. Sun F, et al. Among authors: han y. Oncotarget. 2017 Apr 19;8(31):51238-51252. doi: 10.18632/oncotarget.17228. eCollection 2017 Aug 1. Oncotarget. 2017. PMID: 28881644 Free PMC article.

8

CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.

Han Y, Sun F, Zhang X, Wang T, Jiang J, Cai J, Gao Q, Hezam K, Liu Y, Xie J, Wang M, Zhang J. Han Y, et al. J Cancer Res Clin Oncol. 2019 May;145(5):1179-1190. doi: 10.1007/s00432-019-02865-8. Epub 2019 Feb 18. J Cancer Res Clin Oncol. 2019. PMID: 30778749

9

Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1 (HS3ST3B1) promotes angiogenesis and proliferation by induction of VEGF in acute myeloid leukemia cells.

Zhang L, Song K, Zhou L, Xie Z, Zhou P, Zhao Y, Han Y, Xu X, Li P. Zhang L, et al. Among authors: han y. J Cell Biochem. 2015 Jun;116(6):1101-12. doi: 10.1002/jcb.25066. J Cell Biochem. 2015. PMID: 25536282

10

Rerouting Native HDL to Predetermined Receptors for Improved Tumor-Targeted Gene Silencing Therapy.

Ding Y, Han Y, Wang R, Wang Y, Chi C, Zhao Z, Zhang H, Wang W, Yin L, Zhou J. Ding Y, et al. Among authors: han y. ACS Appl Mater Interfaces. 2017 Sep 13;9(36):30488-30501. doi: 10.1021/acsami.7b10047. Epub 2017 Aug 30. ACS Appl Mater Interfaces. 2017. PMID: 28828863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,243 results

Search Page

Filters